Fiera Capital (Canada)
SAGE

Fiera Capital (Canada)’s Sage Therapeutics SAGE Stock Holding History

Fiera Capital (Canada)’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-189,258
Closed -$13.7M – 684
2019
Q4 		$13.7M Sell
189,258
-105,768
-36% -$13M 0.05% 189
2019
Q3 		$41.4M Sell
295,026
-5,778
-2% -$967K 0.15% 101
2019
Q2 		$55.1M Sell
300,804
-12,079
-4% -$2.06M 0.21% 81
2019
Q1 		$49.8M Buy
312,883
+66,138
+27% +$9.58M 0.19% 92
2018
Q4 		$23.6M Sell
246,745
-16,790
-6% -$1.92M 0.11% 153
2018
Q3 		$37.2M Sell
263,535
-10,383
-4% -$1.6M 0.15% 126
2018
Q2 		$42.9M Buy
273,918
+243,118
+789% +$38.2M 0.19% 107
2018
Q1 		$4.96M Sell
30,800
-3,976
-11% -$675K 0.02% 292
2017
Q4 		$5.73M Sell
34,776
-6,873
-17% -$666K 0.03% 293
2017
Q3 		$2.59M Buy
+41,649
New +$3.27M 0.01% 356

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Fiera Capital (Canada)'s SAGE Position: Q1 2020 in Review

Fiera Capital (Canada) sold out of Sage Therapeutics (SAGE) in Q1 2020, closing a stake of 189,258 shares — an estimated $13.7M sold.

Fiera Capital (Canada) first reported a position in SAGE in Q3 2017 and held it in 10 quarters. The position peaked at $55.1M in Q2 2019. 230 funds tracked by Wall St. Rank hold SAGE as of Q1 2020.

  • Fiera Capital (Canada) reported no remaining Sage Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Fiera Capital (Canada) sold 189,258 Sage Therapeutics shares in Q1 2020, an estimated $13.7M.
  • Fiera Capital (Canada) first reported a position in Sage Therapeutics in Q3 2017 and held it in 10 quarters.
  • Fiera Capital (Canada)'s Sage Therapeutics position peaked at $55.1M in Q2 2019.
  • 230 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2020.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2020, filed 8 May 2020.